Study identifier:NIS-GEU-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
European Survey of Non-Variceal Upper Gastro Intestinal Bleeding
Non-variceal upper gastrointestinal bleeding
-
No
-
All
2500
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The aim of this study is to assess the current management strategies in a pan-European “real-life” setting to uncover the unmet need in this area: non-variceal gastrointestinal bleedings.
Location
Location
S. Giovanni Rotondo, Italy
Location
Napoli, Italy
Location
Trieste, Italy
Location
Revenna, Italy
Location
Bolzano, Italy
Location
Roma, Italy
Location
Novara, Italy
Location
Milano, Italy
Arms | Assigned Interventions |
---|---|
1 Patients admitted to the hospital, or inpatients admitted for another reason, presenting with overt non-variceal upper GI bleed manifesting as hematemesis/coffee ground vomiting, melena, hematochezia, as well as other clinical or laboratory evidence of acute blood loss from the upper gastrointestinal tract | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.